Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 8, 2001, Pages 3815-3819

  Yang, Wei Shiung ^a   Lee, Wei Jei ^c   Funahashi, Tohru ^d   Tanaka, Sachiyo ^d   Matsuzawa, Yuji ^d   Chao, Chia Ling ^a,b   Chen, Chi Ling ^a,b   Tai, Tong Yuan ^a   Chuang, Lee Ming ^a,e  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c EN CHU KONG HOSPITAL   (Taiwan)

^d OSAKA UNIVERSITY   (Japan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CYTOKINE; GLUCOSE; PLASMA PROTEIN; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION FUNCTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; MULTIVARIATE ANALYSIS; NEGATIVE FEEDBACK; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; SEX DIFFERENCE; STOMACH PARTITIONING; WEIGHT REDUCTION;

EID: 0034891684     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.8.7741     Document Type: Article

References (27)

1. The disease burden associated with overweight and obesity
2. Annual deaths attributable to obesity in the United States
3. Body-mass index and mortality in a prospective cohort of U.S. adults
4. Molecular mechanism of metabolic syndrome X: Contribution of adipocytokines adipocyte-derived bioactive substances
5. Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity
6. Human leptin deficiency caused by a missense mutation: Multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects
7. Enhanced expression of PAI-1 in visceral fat: Possible contributor to vascular disease in obesity
8. Adipose expression of tumor necrosis factor-α: Direct role in obesity-linked insulin resistance
9. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1
10. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma
11. Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin
12. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway
13. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages
14. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls
15. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity
16. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients
17. AdipoQ is a novel adipocyte-specific gene dysregulated in obesity
18. Effect of thiazolidinedione on gene expression in NIH3T3-L1 adipocytes
19. The expression of adipogenic genes is decreased in obesity and diabetes mellitus
20. Fifteen years' experience with gastric partitioning for obesity treatment
21. Intentional weight loss and mortality among overweight individuals with diabetes
22. Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults
23. Gastrointestinal surgery for severe obesity
24. Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test
25. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
26. Proteolytic cleavage product of 30 Kd adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice
27. A novel serum protein similar to C1q, produced exclusively in adipocytes